Vishwavijay Singh

Vishwavijay Singh has a diverse work experience spanning over several years. In their most recent role at Azurity Pharmaceuticals, they hold the position of Vice President of Portfolio Management. Prior to this, they served as a Principal at Axtria - Ingenious Insights.

Singh's previous experience includes working at Dr. Reddy's Laboratories as the Lead for BD, Strategy, and Analytics for Proprietary Products. During their time there, they played a key role in developing the go-to-market strategy for a late-stage immuno-oncology asset named E7777. Vishwavijay also led multiple M&A transactions, including the sale of E7777 rights to Citius Pharma.

Before joining Dr. Reddy's Laboratories, Singh served as the Head of Analytics and Insights at Promius Pharma. Vishwavijay was also the Vice President of Business Development at Cobbs Creek Healthcare and worked in various roles at Dr. Reddy's Laboratories, starting as an Associate Director of Corporate Development for Proprietary Products.

Singh began their career as an Assistant Manager in Marketing at Saurav Chemicals Limited and gained initial experience as a Management Trainee in Sales & Marketing at Sandoz.

Overall, Vishwavijay Singh has demonstrated expertise in portfolio management, strategy development, M&A transactions, and business development across the pharmaceutical industry.

Vishwavijay Singh's education history includes a variety of academic pursuits. Vishwavijay obtained an MBA in Pharmaceutical Management from the National Institute of Pharmaceutical Education and Research. Additionally, they completed a course in Negotiations at the Indian Institute of Management Ahmedabad. Vishwavijay also holds a Bachelor's degree in Pharmacy from Babasaheb Bhimrao Ambedkar Bihar University, specializing in Pharmaceutical Sciences. Vishwavijay further pursued a Post Graduate Diploma in Patents Law at the National Academy of Legal Studies & Research (NALSAR) University Hyderabad. Continuing their education, Vishwavijay completed a program on In-licensing and Out-licensing in the Pharmaceutical Industry at the National University of Singapore. Lastly, they obtained a Regulatory Affairs Certificate from the Regulatory Affairs Professional Society (RAPS), focusing on Regulatory Affairs.